Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adlay-derived flavonoids are a group of novel small molecule compounds extracted from Adlay (*Coix lacryma-jobi*), currently under development by Joben Bio Medical. These botanical-derived substances are being investigated for their potential in treating various anti-inflammatory indications. As of the current reporting, the candidate is in the preclinical stage of development, with research focusing on the characterization of these novel flavonoids and their therapeutic efficacy in inflammatory models. The company's R&D efforts leverage the traditional medicinal properties of Adlay seeds to identify specific flavonoid fractions with potent biological activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on adlay-derived flavonoids.